GL1X · GenesisL1 explorer

Research workbench

Crystal structure of the dbd domain of human DNA ligase IV apo form

Analyse Crystal structure of the dbd domain of human DNA ligase IV apo form in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4HTO
Type
protein
Length
214 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
DNA ligase 4
EC
6.5.1.1
UniProt
P49917
Ligands
PO4
Pockets
1 · best druggability 0.37

Structure

x-ray diffraction · 1 distinct chain · 64% helix, 2% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ADNA ligase 4 (EC 6.5.1.1)protein21464% helix, 2% strandP49917

Ligands and binding sites

  • PO4 · Phosphate ion · ion · 2 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1510.370.8011empty

Compared structures

  • 4HTO · Crystal structure of the DBD domain of human DNA ligase IV Apo form · the same entry in another collection · chain A against A, TM-score 1.00
  • P49917 · AlphaFold monomer V2.0 prediction for DNA ligase 4 (P49917) · a predicted model of the same protein · chain A against A, TM-score 0.86

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.